Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Leerink Partners Downgrades Shockwave Medical to Market Perform, Lowers Price Target to $335

Author: Benzinga Newsdesk | April 08, 2024 01:24pm
Leerink Partners analyst Mike Kratky downgrades Shockwave Medical (NASDAQ:SWAV) from Outperform to Market Perform and lowers the price target from $361 to $335.

Posted In: SWAV


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist